Interestingly, hypomethylation of the MCP-1 promoter associated with increased serum MCP-1 levels, HbA1c, and fasting blood glucose levels in patients with T2D compared to healthy controls (43). The gene discussed is CCL2; the disease is type 2 diabetes mellitus.